{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:42:52Z","timestamp":1791520972225,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T00:00:00Z","timestamp":1606694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["HHSN275201800001I"],"award-info":[{"award-number":["HHSN275201800001I"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["162208"],"award-info":[{"award-number":["162208"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["149046"],"award-info":[{"award-number":["149046"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000222","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","award":["G-17-0018613"],"award-info":[{"award-number":["G-17-0018613"]}],"id":[{"id":"10.13039\/501100000222","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["500865"],"award-info":[{"award-number":["500865"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003784","name":"Great Ormond Street Hospital for Children","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000765","name":"University College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002879","name":"Canadian HIV Trials Network, Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002879","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HHSN275201800001I"],"award-info":[{"award-number":["HHSN275201800001I"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012618","name":"National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ebiom.2020.103167","type":"journal-article","created":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T06:03:32Z","timestamp":1608271412000},"page":"103167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels"],"prefix":"10.1016","volume":"63","author":[{"given":"Haneesha","family":"Mohan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica Guzman","family":"Lenis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn Y.","family":"Laurette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Tejada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanvi","family":"Sanghvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kit-Yi","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay S.","family":"Cahill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Sled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Delgado-Olgu\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas D.E.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Copp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2817-6134","authenticated-orcid":false,"given":"Lena","family":"Serghides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2020.103167_bib0001","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1097\/QAD.0000000000001845","article-title":"The transition to dolutegravir and other new antiretrovirals in low-income and middle-income countries: what are the issues?","volume":"32","author":"Vitoria","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.ebiom.2020.103167_bib0002","series-title":"Recommendations for a Public Health Approach","year":"2016"},{"key":"10.1016\/j.ebiom.2020.103167_bib0003","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1056\/NEJMc1807653","article-title":"Neural-tube defects with dolutegravir treatment from the time of conception","volume":"379","author":"Zash","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ebiom.2020.103167_bib0004","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1056\/NEJMoa1905230","article-title":"Neural-tube defects and antiretroviral treatment regimens in Botswana","volume":"381","author":"Zash","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ebiom.2020.103167_bib0005","series-title":"Update on Neural Tube Defects With Antiretroviral Exposure in the Tsepamo Study","author":"R. Zash","year":"2020"},{"key":"10.1016\/j.ebiom.2020.103167_bib0006","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMc1908155","article-title":"Dolutegravir use at conception \u2013 additional surveillance data from Botswana","volume":"381","author":"Raesima","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ebiom.2020.103167_bib0007","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10096-018-3195-9","article-title":"Dolutegravir in pregnancy-effects on HIV-positive women and their infants","volume":"37","author":"Bornhede","year":"2018","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ebiom.2020.103167_bib0008","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1097\/QAD.0000000000001931","article-title":"Evaluating outcomes of mother-infant pairs using dolutegravir for HIV treatment during pregnancy","volume":"32","author":"Grayhack","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.ebiom.2020.103167_bib0009","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/QAI.0000000000002035","article-title":"Pregnancy and neonatal outcomes following prenatal exposure to dolutegravir","volume":"81","author":"Vannappagari","year":"2019","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.ebiom.2020.103167_bib0010","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/1471-0528.15838","article-title":"Congenital anomalies following antenatal exposure to dolutegravir: a Canadian surveillance study","volume":"126","author":"Money","year":"2019","journal-title":"BJOG"},{"key":"10.1016\/j.ebiom.2020.103167_bib0011","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/QAD.0000000000001755","article-title":"Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV","volume":"32","author":"Mulligan","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.ebiom.2020.103167_bib0012","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S2055-6640(20)30247-8","article-title":"Safety and pharmacokinetics of dolutegravir in HIV-positive pregnant women: a systematic review","volume":"4","author":"Hill","year":"2018","journal-title":"J. Virus Erad."},{"key":"10.1016\/j.ebiom.2020.103167_bib0013","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/QAI.0000000000002065","article-title":"Is there a safety signal for dolutegravir and integrase inhibitors during pregnancy","volume":"81","author":"Chouchana","year":"2019","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.ebiom.2020.103167_bib0014","unstructured":"The Antiretroviral Pregnancy Registry interim report, 1 January 1989 through 31 Janurary 2020 (http:\/\/www.apregistry.com\/forms\/interim_report.pdf)."},{"key":"10.1016\/j.ebiom.2020.103167_bib0015","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1473-3099(20)30117-1","article-title":"Dolutegravir and neural tube defects: a new insight","volume":"20","author":"Chouchana","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ebiom.2020.103167_bib0016","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.yrtph.2012.03.009","article-title":"Testing strategies for embryo-fetal toxicity of human pharmaceuticals. Animal models vs. in vitro approaches: a workshop report","volume":"63","author":"Van der Laan","year":"2012","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.ebiom.2020.103167_bib0017","doi-asserted-by":"crossref","first-page":"209","DOI":"10.5507\/bp.2005.027","article-title":"Developmental toxicology \u2013 an integral part of safety evaluation of new drugs","volume":"149","author":"Ujh\u00e1zy","year":"2005","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc. Czech Repub."},{"key":"10.1016\/j.ebiom.2020.103167_bib0018","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/bdr2.1635","article-title":"Absence of developmental and reproductive toxicity in animals exposed to dolutegravir","volume":"112","author":"Stanislaus","year":"2020","journal-title":"Birth Defects Res."},{"key":"10.1016\/j.ebiom.2020.103167_bib0019","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.antiviral.2018.09.008","article-title":"Improving the clinical relevance of a mouse pregnancy model of antiretroviral toxicity; a pharmacokinetic dosing-optimization study of current HIV antiretroviral regimens","volume":"159","author":"Kala","year":"2018","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ebiom.2020.103167_bib0020","doi-asserted-by":"crossref","first-page":"e3802","DOI":"10.1002\/nbm.3802","article-title":"Partitioning k-space for cylindrical three-dimensional rapid acquisition with relaxation enhancement imaging in the mouse brain","volume":"30","author":"Spencer Noakes","year":"2017","journal-title":"NMR Biomed."},{"key":"10.1016\/j.ebiom.2020.103167_bib0021","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.celrep.2017.10.072","article-title":"Partitioning of one-carbon units in folate and methionine metabolism is essential for neural tube closure","volume":"21","author":"Leung","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.ebiom.2020.103167_bib0022","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1038\/ncomms7388","article-title":"Glycine decarboxylase deficiency causes neural tube defects and features of non-ketotic hyperglycinemia in mice","volume":"6","author":"Pai","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ebiom.2020.103167_bib0023","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11010-013-1613-y","article-title":"Folate metabolite profiling of different cell types and embryos suggests variation in folate one-carbon metabolism, including developmental changes in human embryonic brain","volume":"378","author":"Leung","year":"2013","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.ebiom.2020.103167_bib0024","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2202-14-37","article-title":"Improving basic and translational science by accounting for litter-to-litter variation in animal models","volume":"14","author":"Lazic","year":"2013","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.ebiom.2020.103167_bib0025","first-page":"375","article-title":"Clinical chemistry reference intervals for C57BL\/6J, C57BL\/6N, and C3HeB\/FeJ Mice (Mus musculus)","volume":"55","author":"Otto","year":"2016","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"key":"10.1016\/j.ebiom.2020.103167_bib0026","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1528-1157.44.s3.5.x","article-title":"Pathobiology and genetics of neural tube defects","volume":"44","author":"Finnell","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebiom.2020.103167_bib0027","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev-neuro-062012-170354","article-title":"Neural tube defects","volume":"37","author":"Greene","year":"2014","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ebiom.2020.103167_bib0028","article-title":"Effects and safety of periconceptional oral folate supplementation for preventing birth defects","volume":"12","author":"De-Regil","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ebiom.2020.103167_bib0029","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S1474-4422(13)70110-8","article-title":"Neural tube defects: recent advances, unsolved questions, and controversies","volume":"12","author":"Copp","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ebiom.2020.103167_bib0030","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1124\/dmd.119.087635","article-title":"Clinical extrapolation of the effects of dolutegravir and other HIV integrase inhibitors on folate transport pathways","volume":"47","author":"Zamek-Gliszczynski","year":"2019","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ebiom.2020.103167_bib0031","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1097\/QAD.0000000000002289","article-title":"The antagonism of folate receptor by dolutegravir: developmental toxicity reduction by supplemental folic acid","volume":"33","author":"Cabrera","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.ebiom.2020.103167_bib0032","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/jez.1401660104","article-title":"Congenital eye defects in the mouse I: corneal opacity in C57black mice","volume":"166","author":"Pierro","year":"1967","journal-title":"J. Exp. Zool."},{"key":"10.1016\/j.ebiom.2020.103167_bib0033","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ejmg.2014.05.002","article-title":"The genetic architecture of microphthalmia, anophthalmia and coloboma","volume":"57","author":"Williamson","year":"2014","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.ebiom.2020.103167_bib0034","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nature09729","article-title":"Tbx6-dependent Sox2 regulation determines neural or mesodermal fate in axial stem cells","volume":"470","author":"Takemoto","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2020.103167_bib0035","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/sj.embor.7400184","article-title":"Restriction of BMP4 activity domains in the developing neural tube of the mouse embryo","volume":"5","author":"Hu","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ebiom.2020.103167_bib0036","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1097\/QAD.0000000000002550","article-title":"Safety of in-utero antiretroviral exposure: neurologic outcomes in children who are HIV-exposed but uninfected","volume":"34","author":"Crowell","year":"2020","journal-title":"AIDS"},{"key":"10.1016\/j.ebiom.2020.103167_bib0037","first-page":"110","article-title":"Lymphodynamics in the fetus and newborn","volume":"39","author":"Bellini","year":"2006","journal-title":"Lymphology"},{"key":"10.1016\/j.ebiom.2020.103167_bib0038","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/humupd\/dmp052","article-title":"Teratogenic mechanisms of medical drugs","volume":"16","author":"Van Gelder","year":"2010","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.ebiom.2020.103167_bib0039","article-title":"Unexpected interactions between dolutegravir and folate: randomised trial evidence from South Africa","author":"Chandiwana","year":"2020","journal-title":"AIDS"},{"key":"10.1016\/j.ebiom.2020.103167_bib0040","first-page":"20","article-title":"Molecular biology of 5,10-methylenetetrahydrofolate reductase","volume":"13","author":"F\u00f6dinger","year":"2000","journal-title":"J. Nephrol."},{"key":"10.1016\/j.ebiom.2020.103167_bib0041","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.2174\/1381612823666170317124913","article-title":"Homocysteine and non-cardiac vascular disease","volume":"23","author":"Katsiki","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ebiom.2020.103167_bib0042","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1038\/s41598-018-21019-3","article-title":"Plasma homocysteine concentrations and risk of intracerebral hemorrhage: a systematic review and meta-analysis","volume":"8","author":"Zhou","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ebiom.2020.103167_bib0043","doi-asserted-by":"crossref","DOI":"10.1177\/1559325818798282","article-title":"Nonmonotonic dose-response curves occur in dose ranges that are relevant to regulatory decision-making","volume":"16","author":"Hill","year":"2018","journal-title":"Dose Response"},{"key":"10.1016\/j.ebiom.2020.103167_bib0044","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1210\/er.2011-1050","article-title":"Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses","volume":"33","author":"Vandenberg","year":"2012","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ebiom.2020.103167_bib0045","doi-asserted-by":"crossref","first-page":"11376","DOI":"10.1038\/srep11376","article-title":"Non-monotonic dynamics and crosstalk in signaling pathways and their implications for pharmacology","volume":"5","author":"van Wijk","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ebiom.2020.103167_bib0046","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/jac\/dkv358","article-title":"Placental transfer of the HIV integrase inhibitor dolutegravir in an ex vivo human cotyledon perfusion model","volume":"71","author":"Schalkwijk","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ebiom.2020.103167_bib0047","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1293\/tox.24.95","article-title":"Toxicological pathology in the rat placenta","volume":"24","author":"Furukawa","year":"2011","journal-title":"J. Toxicol. Pathol."},{"key":"10.1016\/j.ebiom.2020.103167_bib0048","doi-asserted-by":"crossref","first-page":"614","DOI":"10.7326\/M18-3358","article-title":"Risks and benefits of dolutegravir- and efavirenz-based strategies for South African women with HIV of child-bearing potential: a modeling study","volume":"170","author":"Dugdale","year":"2019","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ebiom.2020.103167_bib0049","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1056\/NEJMp1908843","article-title":"Health care autonomy of women living with HIV","volume":"381","author":"Redfield","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ebiom.2020.103167_bib0050","doi-asserted-by":"crossref","first-page":"e25352","DOI":"10.1002\/jia2.25352","article-title":"Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects","volume":"22","author":"Mofenson","year":"2019","journal-title":"J. Int. AIDS Soc."}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420305430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420305430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:33:13Z","timestamp":1778873593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396420305430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":50,"alternative-id":["S2352396420305430"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.103167","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.103167","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103167"}}